Skip to content

LONA LONA Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$106.27K+690%
Erasca, Inc. logo
Erasca, Inc.ERAS

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+235%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: LONA’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's payments of stock issuance costs?
LONA (LONA) reported payments of stock issuance costs of $1.89M in Q4 2025.
What does payments of stock issuance costs mean?
This represents the direct cash expenditures, such as legal, accounting, and underwriting fees, incurred in connection with the issuance of new equity securities. These costs are typically deducted from the gross proceeds of a capital raise to determine the net cash received from financing activities. Tracking these costs is important for evaluating the efficiency and cost-effectiveness of the company's capital-raising efforts.